Testing asciminib with trastuzumab for HER2+ breast cancer that has spread to the brain
Original title: Asciminib in HER2+ Breast Cancer Brain Metastases
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early test in people, so it is not treatment you can get from your own doctor.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing whether two drugs given together can help brain tumors that came from HER2+ breast cancer.
Who this trial is for. This trial is for people with HER2+ breast cancer that has spread to the brain. It tests the drug asciminib given together with trastuzumab.
Where it stands. There are no results yet. The study is measuring how the tumors in the brain respond to the two drugs. That answer is not in yet. The trial has not reported results.
What this means, and what it doesn't
What it could mean: If this sounds like your situation, you can ask your care team about it. They can help you think through whether a trial like this fits you.
What it doesn't mean: This does not mean the drug pair is known to work. A trial is a test, not a proven treatment. Being in a trial is not a guarantee that it will help you. It is not a promise of a cure.
Source: ClinicalTrials.gov, July 22, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.